The Origin of Epithelial Neoplasms of the Ovary: An Alternative View

Advances in Anatomic Pathology

Volumn 23, Issue 1, 2016, Pages 50-57

  Silva, Elvio G ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

clonality; fallopian tube; fere ex nihilo; ovarian neoplasms

Indexed keywords

ALCOHOL; BRCA1 PROTEIN; PROTEIN P53; TALC;

ALCOHOL CONSUMPTION; BREAST CANCER; CANCER RISK; CANCER STAGING; CLONAL VARIATION; EPITHELIAL OVARIAN NEOPLASM; EPITHELIUM TUMOR; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; GONADAL DYSGENESIS; HUMAN; INVASIVE CARCINOMA; MESOTHELIOMA; MISMATCH REPAIR; MUMPS; OVARIAN MESOTHELIOMA; OVARY CANCER; OVARY CARCINOMA; OVARY TUMOR; OVULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOTHERAPY; REVIEW; SMOKING; UTERINE TUBE; FALLOPIAN TUBE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY;

FALLOPIAN TUBES; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 84951774635     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0000000000000098     Document Type: Review

References (66)

1. Huncharek M, Geschwind JF, Kupelnick B. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res. 2003;23:1955-1960.
2. Cramer DW, Vitonis AF, Pinheiro SP, et al. Mumps and ovarian cancer: modern interpretation of an historic association. Cancer Causes Control. 2010;21:1193-1201.
3. Menczer J, Modan M, Ranon L, et al. Possible role of mumps virus in the etiology of ovarian cancer. Cancer. 1979;43: 1375-1379.
4. Webb PM, Purdie DM, Bain CJ, et al. Alcohol, wine, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:592-599.
5. Furth J, Butterworth JS. Neoplastic diseases occurring among mice subjected to general irradiation with X-rays. Am J Cancer. 1936;28:66.
6. Fathalla MF. Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Surv. 1972;27:751-768.
7. Hakim AA, Barry CP, Barnes HJ, et al. Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2/neu. Cancer Prev Res. 2009;2:114-121.
8. Parmley TH, Woodruff JD. The ovarian mesothelioma. Am J Obstet Gynecol. 1974;120:234-241.
9. Ordonez NG. Value of PAX8, PAX2, claudin-4, and Hcaldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Mod Pathol. 2013;26:553-562.
10. Hunn J, Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol. 2012;55:3-23.
11. Ketabi Z, Bartuma K, Bernstein I, et al. Ovarian cancer linked to Lynch syndrome typically presents as early-onset, nonserous epithelial tumors. Gynecol Oncol. 2011;121:462-465.
12. Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001;195: 451-456.
13. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol. 2008;27:1-9.
14. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31:161-169.
15. Lee Y, Medeiros F, Kindelberger D, et al. Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol. 2006;13:1-7.
16. Barzilai G. Endosalpingioma of the Ovary. New York City, NY: Gune & Stratton; 1949.
17. Colgan TJ. Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations. Int J Gynecol Pathol. 2003;22:109-120.
18. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230-236.
19. Rabban JT, Krasik E, Chen LM, et al. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol. Am J Surg Pathol. 2009;33:1878-1885.
20. Vang R, Shih IEM, Kurman RJ. Fallopian tube precursors of ovarian low-and high-grade serous neoplasms. Histopathology. 2013;62:44-58.
21. Kuhn E, Meeker A, Wang TL, et al. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol. 2010;34:829-836.
22. Li J, Abushahin N, Pang S, et al. Tubal origin of 'ovarian' lowgrade serous carcinoma. Mod Pathol. 2011;24:1488-1499.
23. Alvarado-Cabrero I, Stolnicu S, Kiyokawa T, et al. Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors. Ann Diagn Pathol. 2013;17:159-164.
24. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 2010.
25. Delgado G, Oram DH, Petrilli ES. Stage III epithelial ovarian cancer: the role of maximal surgical reduction. Gynecol Oncol. 1984;18:293-298.
26. Smith JP, Day TG Jr. Rewiew of ovarian cancer at the University of Texas Systems Cancer Center, M.D. Anderson Hospital and Tumor Institute. Am J Obstet Gynecol. 1979;135: 984-993.
27. Price MJ, Ades AE, De Angelis D, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178:484-492.
28. Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know Sex Transm Infect. 2000;76:80-87.
29. Feldman GB, Knapp RC. Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer. Am J Obstet Gynecol. 1974;119:991-994.
30. del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol. 2012;126:481-490.
31. Gershenson DM, Del Junco G, Herson J, et al. Endodermal sinus tumor of the ovary: the M. D. Anderson experience. Obstet Gynecol. 1983;61:194-202.
32. Min KW, Park MH, Hong SR, et al. Clear cell carcinomas of the ovary: a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3. Int J Gynecol Pathol. 2013;32:3-14.
33. Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin Am J Surg Pathol. 2010;34:1407-1416.
34. Hanamornroongruang S, Lin D, Meserve EE, et al. Unique ("set") histologic features correlate with Tubal intraepithelial carcinoma in women with and without BRCA mutations. Mod Pathol. 2014;27:285A.
35. Meserve EE, H B, Conner JR, et al. Does BRCA+ pelvic serous cancer have a dual pathogenesis: the paradox of tubal intraepithelial carcinoma (tic), early and advanced disease. Mod Pathol. 2014;27:296A.
36. LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol. 1988;19:1080-1084.
37. Rutgers JL, Scully RE. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer. 1988;61:340-348.
38. Silva EG, Tornos C, Zhuang Z, et al. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol. 1998;17:1-6.
39. Wani Y, Notohara K. Ovarian clear cell carcinoma arising in a mucinous cystadenoma. Int J Gynecol Pathol. 2009;28:584-588.
40. Stewart CJ, Leung YC, Whitehouse A. Fallopian tube metastases of non-gynaecological origin: a series of 20 cases emphasizing patterns of involvement including intra-epithelial spread. Histopathology. 2012;60:E106-E114.
41. Silva EG, Matias-Guiu X. Clonality in gynecologic neoplasms: is it time to reevaluate clonality studies in gynecologic neoplasms Is it possible to confirm multicentricity with clonality studies Ann Diagn Pathol. 2012;16:312-314.
42. Imamura F, Aono H, Hasunuma T, et al. Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum. 1998;41:1979-1986.
43. Braakhuis BJ, Tabor MP, Kummer JA, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63: 1727-1730.
44. Jovanovic L, Delahunt B, McIver B, et al. Thyroid gland clonality revisited: the embryonal patch size of the normal human thyroid gland is very large, suggesting X-chromosome inactivation tumor clonality studies of thyroid tumors have to be interpreted with caution. J Clin Endocrinol Metab. 2003;88:3284-3291.
45. Lindgren D, Gudjonsson S, Jee KJ, et al. Recurrent and multiple bladder tumors show conserved expression profiles. BMC Cancer. 2008;8:183.
46. Louhelainen J, Wijkstrom H, Hemminki K. Allelic losses demonstrate monoclonality of multifocal bladder tumors. Int J Cancer. 2000;87:522-527.
47. Worsham MJ, Wolman SR, Carey TE, et al. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol. 1995;26:251-261.
48. Quade BJ, McLachlin CM, Soto-Wright V, et al. Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol. 1997;150:2153-2166.
49. Kupryjanczyk J, Thor AD, Beauchamp R, et al. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. Mod Pathol. 1996;9:166-173.
50. Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
51. Herreros-Villanueva M, Zhang JS, Koenig A, et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis. 2013;2:e61.
52. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63:5821-5828.
53. Stewart CJ, McCluggage WG. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology. 2013;62:31-43.
54. Visser JA, McLuskey A, Verhoef-Post M, et al. Effect of prenatal exposure to diethylstilbestrol on Mullerian duct development in fetal male mice. Endocrinology. 1998;139: 4244-4251.
55. Saffos RO, Rhatigan RM, Scully RE. Metaplastic papillary tumor of the fallopian tube-a distinctive lesion of pregnancy. Am J Clin Pathol. 1980;74:232-236.
56. Mooney J, Silva E, Tornos C, et al. Unusual features of serous neoplasms of low malignant potential during pregnancy. Gynecol Oncol. 1997;65:30-35.
57. Fauvet R, Brzakowski M, Morice P, et al. Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter study. Ann Oncol. 2012;23:1481-1487.
58. Silva EG, Tornos C, Fritsche HA Jr, et al. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod Pathol. 1997;10:879-883.
59. Silva EG, Tornos C, Deavers M, et al. Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation. Gynecol Oncol. 1998;71:240-246.
60. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into peritoneal cavity. Am J Obstet Gynecol. 1927;14:422-469.
61. Dauge MC, Delmas V, Grossin M, et al. Disseminated peritoneal leiomyomatosis associated with endometriosis. Apropos of a case. Ann Pathol. 1986;6:221-224.
62. Corben AD, Nehhozina T, Garg K, et al. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma. Am J Surg Pathol. 2010;34: 1211-1216.
63. Djordjevic B, Clement-Kruzel S, Atkinson NE, et al. Nodal endosalpingiosis in ovarian serous tumors of low malignant potential with lymph node involvement: a case for a precursor lesion. Am J Surg Pathol. 2010;34:1442-1448.
64. Silva EG, Gershenson DM, Malpica A, et al. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006;30:1367-1371.
65. Anderson CK, Wallace S, Guiahi M, et al. Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer. Int J Gynecol Cancer. 2013;23:417-421.
66. Olivier RI, Lubsen-Brandsma LA, van Boven H, et al. Additional salpingectomy after previous prophylactic oophorectomy in high-risk women: sense or nonsense Gynecol Oncol. 2005;96:439-443.